HCPCS Level IIdrugActive
J2350
Injection, ocrelizumab, 1 mg
BETOS: O1E
Effective: 2018-01-01
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Ocrevus
Manufacturer
Genentech, Inc.
HCPCS Dosage
1 MG
Billing Units
300.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.
Drug Products
FDA-registered drug products mapped to this HCPCS code